Correlation Between Immix Biopharma and Atea Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Immix Biopharma and Atea Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immix Biopharma and Atea Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Immix Biopharma and Atea Pharmaceuticals, you can compare the effects of market volatilities on Immix Biopharma and Atea Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immix Biopharma with a short position of Atea Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immix Biopharma and Atea Pharmaceuticals.

Diversification Opportunities for Immix Biopharma and Atea Pharmaceuticals

0.68

Correlation Coefficient

Immix Biopharma  Atea Pharmaceuticals

Poor diversification

The 3 months correlation between Immix and Atea is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and Atea Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atea Pharmaceuticals and Immix Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immix Biopharma are associated (or correlated) with Atea Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atea Pharmaceuticals has no effect on the direction of Immix Biopharma i.e., Immix Biopharma and Atea Pharmaceuticals go up and down completely randomly.

Pair Corralation between Immix Biopharma and Atea Pharmaceuticals

Given the investment horizon of 90 days Immix Biopharma is expected to under-perform the Atea Pharmaceuticals. In addition to that, Immix Biopharma is 1.79 times more volatile than Atea Pharmaceuticals. It trades about -0.06 of its total potential returns per unit of risk. Atea Pharmaceuticals is currently generating about -0.02 per unit of volatility. If you would invest  333.00  in Atea Pharmaceuticals on December 27, 2024 and sell it today you would lose (15.00) from holding Atea Pharmaceuticals or give up 4.5% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Immix Biopharma  vs.  Atea Pharmaceuticals

Immix Biopharma

Risk-Adjusted Performance

Very Weak

Over the last 90 days Immix Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Atea Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Atea Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable forward indicators, Atea Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Immix Biopharma and Atea Pharmaceuticals

The main advantage of trading using opposite Immix Biopharma and Atea Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immix Biopharma position performs unexpectedly, Atea Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea Pharmaceuticals will offset losses from the drop in Atea Pharmaceuticals' long position.

The idea behind Immix Biopharma and Atea Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.